We continued by examining 14 primary AML samples from the same cohort (due to limited sample availability) and tested various combinations of the depolarization signals elicited by BIM, BAD and HRK peptides at different concentrations (Supplementary Data Set 3). The gene discussed is BAD; the disease is acute myeloid leukemia.